SMITH IAN F 4
4 · Stoke Therapeutics, Inc. · Filed Oct 14, 2025
Insider Transaction Report
Form 4
SMITH IAN F
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-08+570,000→ 570,000 totalExercise: $30.50Exp: 2035-10-07→ Common Stock (570,000 underlying) - Award
Restricted Stock Units
2025-10-08+380,000→ 380,000 totalExp: 2029-10-06→ Common Stock (380,000 underlying)
Footnotes (3)
- [F1]The option shall vest as to 1/4 of the total award on October 6, 2026, with an additional 1/48 of the total award vesting monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F3]The award shall vest as to 1/4 of the total award annually on the sixth calendar day of October, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 6, 2026.